Peak6 Investments LLC Global Blood Therapeutics, Inc. Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $170,598 - $305,583	-3,733 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$45.35 - $57.91 $2,040 - $2,605	-45 Reduced 1.19%	3,733 $181,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $52,757 - $63,479	1,003 Added 36.14%	3,778 $199,000
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $541,624 - $724,333	-13,544 Reduced 83.0%	2,775 $147,000
Q4 2018 Feb 13, 2019	BUY	$31.54 - $46.67 $514,701 - $761,607	16,319 New	16,319 $670,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.